Proposed Data Collections Submitted for Public Comment and Recommendations, 47848-47850 [2012-19675]
Download as PDF
47848
Federal Register / Vol. 77, No. 155 / Friday, August 10, 2012 / Notices
Background and Brief Description of the
Proposed Project
One of the objectives of CDC’s
epidemic services is to provide for the
prevention and control of epidemics,
and protect the population from public
health crises such as human-made or
natural biological disasters and
chemical emergencies. CDC meets this
objective, in part, by training
investigators, maintaining laboratory
capabilities for identifying potential
problems, collecting and analyzing data,
and recommending appropriate actions
to protect the public’s health. When
state, local, or foreign health authorities
request help in controlling an epidemic
or solving other health problems, CDC
dispatches skilled epidemiologists from
the Epidemic Intelligence Service (EIS)
to investigate and resolve the problem.
Resolving public health problems
rapidly ensures cost-effective health
care and enhances health promotion
and disease prevention.
The purpose of the Emergency
Epidemic Investigation surveillance is
to collect data from the general public
on the conditions surrounding and
investigations. This mechanism allows
CDC to respond rapidly to public health
problems in need of urgent attention,
thereby providing an important service
to state and other public health
agencies. Through Epi-Aids, EIS officers
(and, sometimes, other CDC trainees)
receive supervised training while
actively participating in epidemiologic
investigations. EIS is a two-year
program of training and service in
applied epidemiology through CDC,
primarily for persons holding doctoral
degrees.
Shortly after completion of the EpiAid investigation, an Epi Trip Report is
delivered to the state health agency
official(s) who requested assistance. The
state and local health officials,
requestors of the Epi-Aid assistance can
comment on both the timeliness and the
practical utility of the recommendations
from the investigation by completing the
Epi-Aid Satisfaction Survey for
Requesting Officials to assess the
promptness of the investigation and the
usefulness of the recommendations.
There is no cost to the respondents
other than their time.
preceding the onset of a problem. The
data is collected from 15,000
respondents in the general public for an
annualized total of 3,750 burden hours
(15,000 respondents × 15 minutes per
survey). These data are collected in a
timely fashion so that information can
be used to develop prevention and
control techniques, to interrupt disease
transmission, and to help identify the
cause of an outbreak. The Epi-Aid
Satisfaction Survey for Requesting
Officials is to assess the promptness of
the investigation and the usefulness of
recommendations; data are collected
from 100 state and local health officials
for an annualized total of 25 burden
hours (100 respondents × 15 minutes
per survey). This survey of state and
local health officials was modified to
better measure and address overall
satisfaction, communication, response,
and team composition and
professionalism of the Epi-Aid team.
The Epi-Aid mechanism is a means for
Epidemic Intelligence Service (EIS)
officers of CDC, along with other CDC
staff, to provide technical support to
state health agencies requesting
assistance with epidemiologic field
ESTIMATED ANNUALIZED BURDEN HOURS
Number of
respondents
Number of
responses per
respondent
Avg burden
per response
(in hours)
Total burden
(in hours)
Respondents
Form Name
Requestors of Epi-Aids .....................
100
1
15/60
25
General Public ...................................
Epi-Aid Satisfaction Survey for Requesting Official.
Emergency Epidemic Investigations
15,000
1
15/60
3,750
Total ...........................................
..........................................................
........................
........................
........................
3,775
Kimberly Lane,
Office of Scientific Integrity, Office of the
Associate Director for Science, Office of the
Director, Centers for Disease Control and
Prevention.
[FR Doc. 2012–19679 Filed 8–9–12; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
mstockstill on DSK4VPTVN1PROD with NOTICES
[60-Day–12–0573]
Proposed Data Collections Submitted
for Public Comment and
Recommendations
In compliance with the requirement
of Section 3506(c)(2)(A) of the
Paperwork Reduction Act of 1995 for
opportunity for public comment on
proposed data collection projects, the
Centers for Disease Control and
VerDate Mar<15>2010
18:02 Aug 09, 2012
Jkt 226001
Prevention (CDC) will publish periodic
summaries of proposed projects. To
request more information on the
proposed projects or to obtain a copy of
the data collection plans and
instruments, call 404–639–7570 and
send comments to Kimberly S. Lane,
1600 Clifton Road, MS–D74, Atlanta,
GA 30333 or send an email to
omb@cdc.gov.
Comments are invited on: (a) Whether
the proposed collection of information
is necessary for the proper performance
of the functions of the agency, including
whether the information shall have
practical utility; (b) the accuracy of the
agency’s estimate of the burden of the
proposed collection of information; (c)
ways to enhance the quality, utility, and
clarity of the information to be
collected; and (d) ways to minimize the
burden of the collection of information
on respondents, including through the
use of automated collection techniques
or other forms of information
PO 00000
Frm 00049
Fmt 4703
Sfmt 4703
technology. Written comments should
be received within 60 days of this
notice.
Proposed Project
National HIV Surveillance System
(NHSS) (OMB No. 0920–0573,
Expiration 01/31/2013)-RevisionNational Center for HIV/AIDS, Viral
Hepatitis, STD, and TB Prevention
(NCHHSTP), Centers for Disease Control
and Prevention (CDC).
Background and Brief Description
CDC is authorized under Sections 304
and 306 of the Public Health Service Act
(42 U.S.C. 242b and 242k) to collect
information on cases of human
immunodeficiency virus (HIV) and
indicators of HIV disease and HIV
disease progression including AIDS.
These national HIV surveillance data
collected by CDC are the primary source
of information used to monitor the
extent and characteristics of the HIV
burden in the U.S.
E:\FR\FM\10AUN1.SGM
10AUN1
47849
Federal Register / Vol. 77, No. 155 / Friday, August 10, 2012 / Notices
The purpose of HIV surveillance is to
monitor trends in HIV and describe the
characteristics of infected persons (e.g.,
demographics, modes of exposure to
HIV, clinical and laboratory markers of
HIV disease, manifestations of severe
HIV disease, and deaths among persons
with HIV). HIV surveillance data are
widely used at all government levels to
assess the impact of HIV infection on
morbidity and mortality, to allocate
medical care resources and services, and
to guide prevention and disease control
activities.
As science, technology, and our
understanding of HIV have evolved, the
NHSS has been updated periodically to
meet the nation’s needs for information.
CDC, in collaboration with health
departments in the 50 states, the District
of Columbia, and U.S. dependent areas,
conduct national surveillance for cases
of HIV infection. National surveillance
includes tracking critical data across the
spectrum of HIV disease from HIV
diagnosis, to AIDS, the end-stage
disease caused by infection with HIV,
and death. In addition, this national
system provides essential data to
estimate HIV incidence and monitor
patterns in viral resistance and HIV–1
subtypes, as well as provide information
on perinatal exposures in the U.S.
The CDC surveillance case definition
has been modified periodically to
accurately monitor disease in adults,
adolescents and children and reflect use
of new testing technologies and changes
in HIV treatment. Information is then
updated in the case report forms and
reporting software as needed. In 2008,
the surveillance case definitions for
adults and children for HIV and AIDS
were revised. Since that time, the
enhanced HIV/AIDS reporting system
(eHARS) was fully deployed (2010) and
forms have been updated to reflect those
changes (2011). In 2012, CDC convened
an expert consultation to consider
revisions of various aspects of the case
definition including criteria for
reporting a potential case, criteria for a
reporting a confirmed case, and case
classification (disease staging system).
Recommendations for revisions in the
may be received from laboratories, vital
statistics offices, or additional
providers. CDC estimates approximately
1,469 updates to case reports will be
processed by each of the 59 health
departments annually. Additionally,
5,876 updates of laboratory test data
will be processed, primarily through
electronic laboratory reporting, by each
of the 59 health departments annually.
Health departments will de-identify
compiled case report information and
forward to CDC on a monthly basis for
inclusion in the national HIV
surveillance database. Evaluations are
also conducted by health departments
on a subset of case reports (e.g.
including re-abstraction/validation
activities and routine interstate deduplication). CDC estimates
approximately 127 evaluations of case
reports will be processed by each of the
jurisdictions annually.
Supplemental surveillance data are
collected in a subset of areas to provide
additional information necessary to
estimate HIV incidence, to better
describe the extent of HIV viral
resistance and quantify HIV subtypes
among persons infected with HIV and to
monitor and evaluate perinatal HIV
prevention efforts. Health departments
funded for these supplemental data
collections obtain this information from
laboratories, health care providers, and
medical records. CDC estimates that
2,729 reports containing HIV Incidence
Surveillance (HIS) data elements will be
processed on average by each of the 25
health departments funded to collect
incidence data annually. Additionally,
an estimated 718 reports containing
additional data elements on HIV
nucleotide sequences from genotype test
results will be processed on average by
each of the 53 health departments
reporting MHS data annually. An
estimated 114 reports containing
perinatal exposure data elements will be
processed on average, annually, by each
of the 35 health departments reporting
data collected as part of PHER.
There are no costs to respondents
except their time.
case definition were adopted in a
position statement by the Council of
State and Territorial Epidemiologists in
June 2012 and the final case definition
revision is planned for 2012.
The revisions requested include
modifications to currently collected data
elements and forms to align with
anticipated changes in the case
definitions for HIV surveillance to be
published in 2012 and continuation of
HIV surveillance activities funded
under the new funding opportunity
announcement CDC–RFA–PS13–1302
National HIV Surveillance System
(NHSS). These include minor
modifications of testing categories to
accommodate new testing algorithms
and modifications to staging criteria and
non-substantial editorial changes aimed
at improving the format and usability of
the forms such as improved wording of
terms and changes in the format of some
response options. In addition, the
number of data elements from the
former enhanced perinatal surveillance
(EPS) was reduced and the form
modified for continuation in 2013 as
Perinatal HIV Exposure Reporting
(PHER). Surveillance data collection on
variant and atypical strains (formerly
variant, atypical and resistant HIV
surveillance (VARHS)) will be
continued as Molecular HIV
Surveillance (MHS) with a reduced
number of data elements previously
approved under VARHS.
CDC provides funding for 59
jurisdictions to conduct adult and
pediatric HIV case surveillance. Health
department staffs compile information
from laboratories, physicians, hospitals,
clinics and other health care providers
in order to complete the HIV and
pediatric case reports. CDC estimates
that approximately 1,260 adult HIV case
reports and 6 pediatric case reports are
processed by each health department
annually.
These data are recorded on standard
case report forms, processed by either
paper or electronic format and entered
into eHARS. Updates to case reports are
also entered into eHARS by health
departments, as additional information
ESTIMATE OF ANNUALIZED BURDEN TABLE
mstockstill on DSK4VPTVN1PROD with NOTICES
Type of respondent
Health
Health
Health
Health
Health
Health
Health
Departments
Departments
Departments
Departments
Departments
Departments
Departments
VerDate Mar<15>2010
..........................
..........................
..........................
..........................
..........................
..........................
..........................
18:02 Aug 09, 2012
Number of
respondents
Form name
Adult HIV Case Report ....................
Pediatric HIV Case Report ...............
Case Report Evaluations .................
Case Report Updates ......................
Laboratory Updates ..........................
HIV Incidence Surveillance (HIS) ....
Molecular HIV Surveillance (MHS) ..
Jkt 226001
PO 00000
Frm 00050
Fmt 4703
Sfmt 4703
Number of
responses per
respondent
59
59
59
59
59
25
53
E:\FR\FM\10AUN1.SGM
1,260
6
127
1,469
5,876
2,729
967
10AUN1
Avg. burden
per response
(in hours)
20/60
20/60
20/60
2/60
1/60
10/60
5/60
Total annual
burden
(in hours)
24,780
118
2,498
2,889
5,778
11,371
4,271
47850
Federal Register / Vol. 77, No. 155 / Friday, August 10, 2012 / Notices
ESTIMATE OF ANNUALIZED BURDEN TABLE—Continued
Number of
responses per
respondent
Number of
respondents
Avg. burden
per response
(in hours)
Total annual
burden
(in hours)
Type of respondent
Form name
Health Departments ..........................
Perinatal HIV Exposure Reporting
(PHER).
35
114
30/60
1,995
Total ...........................................
...........................................................
........................
........................
........................
53,700
Kimberly Lane,
Deputy Director, Office of Scientific Integrity,
Centers for Disease Control and Prevention.
[FR Doc. 2012–19675 Filed 8–9–12; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Board of Scientific Counselors,
National Institute for Occupational
Safety and Health (BSC, NIOSH)
mstockstill on DSK4VPTVN1PROD with NOTICES
In accordance with section 10(a)(2) of
the Federal Advisory Committee Act
(Pub. L. 92–463), the Centers for Disease
Control and Prevention (CDC)
announces the following meeting of the
aforementioned committee:
Time and Date: 8:30 a.m.–3:15 p.m.,
September 18, 2012
Place: Patriots Plaza I, 395 E Street SW.,
Room 9200, Washington, DC 20201.
Status: Open to the public, limited only by
the space available. The meeting room
accommodates approximately 50 people. If
you wish to attend in person, please contact
NIOSH at (202) 245–0625 or (202) 245–0626
for information on building access.
Teleconference is available toll-free; please
dial (877) 328–2816, Participant Pass Code
6558291.
Purpose: The Secretary, the Assistant
Secretary for Health, and by delegation the
Director, Centers for Disease Control and
Prevention, are authorized under Sections
301 and 308 of the Public Health Service Act
to conduct directly or by grants or contracts,
research, experiments, and demonstrations
relating to occupational safety and health and
to mine health. The Board of Scientific
Counselors shall provide guidance to the
Director, National Institute for Occupational
Safety and Health on research and prevention
programs. Specifically, the Board shall
provide guidance on the Institute’s research
activities related to developing and
evaluating hypotheses, systematically
documenting findings and disseminating
results. The Board shall evaluate the degree
to which the activities of the National
Institute for Occupational Safety and Health:
(1) Conform to appropriate scientific
standards, (2) address current, relevant
needs, and (3) produce intended results.
Matters To Be Discussed: NIOSH Director
Update; Implementation of the National
Academies Program Recommendations for
VerDate Mar<15>2010
18:02 Aug 09, 2012
Jkt 226001
Hearing Loss Prevention, Personal Protective
Technologies, and Health Hazard
Evaluations; Construction Safety and Health,
Respiratory Disease Studies, and Traumatic
Injury Prevention.
Agenda items are subject to change as
priorities dictate.
Contact Person for More Information:
Roger Rosa, Ph.D., Designated Federal
Officer, BSC, NIOSH, CDC, 395 E Street SW.,
Suite 9200, Patriots Plaza Building,
Washington, DC 20201, telephone (202) 245–
0655, fax (202) 245–0664.
The Director, Management Analysis and
Services Office, has been delegated the
authority to sign Federal Register notices
pertaining to announcements of meetings and
other committee management activities for
both the Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
Dated: July 27, 2012.
Catherine Ramadei,
Acting Director, Management Analysis and
Services Office, Centers for Disease Control
and Prevention.
[FR Doc. 2012–19248 Filed 8–9–12; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Medicare & Medicaid
Services
[Document Identifier CMS–10203]
Agency Information Collection
Activities: Submission for OMB
Review; Comment Request
Centers for Medicare &
Medicaid Services, HHS.
In compliance with the requirement
of section 3506(c)(2)(A) of the
Paperwork Reduction Act of 1995, the
Centers for Medicare & Medicaid
Services (CMS), Department of Health
and Human Services, is publishing the
following summary of proposed
collections for public comment.
Interested persons are invited to send
comments regarding this burden
estimate or any other aspect of this
collection of information, including any
of the following subjects: (1) The
necessity and utility of the proposed
information collection for the proper
performance of the Agency’s function;
AGENCY:
PO 00000
Frm 00051
Fmt 4703
Sfmt 4703
(2) the accuracy of the estimated
burden; (3) ways to enhance the quality,
utility, and clarity of the information to
be collected; and (4) the use of
automated collection techniques or
other forms of information technology to
minimize the information collection
burden.
1. Type of Information Collection
Request: Revision of a currently
approved collection;
Title of Information Collection:
Medicare Health Outcomes Survey
(HOS); Use: CMS has a responsibility to
its Medicare beneficiaries to require that
care provided by managed care
organizations under contract to CMS is
of high quality. One way of ensuring
high quality care in Medicare Managed
Care Organizations (MCOs), or more
commonly referred to as Medicare
Advantage Organizations (MAOs), is
through the development of
standardized, uniform performance
measures to enable CMS to gather the
data needed to evaluate the care
provided to Medicare beneficiaries. The
goal of the Medicare Health Outcome
Survey (HOS) program is to gather valid,
reliable, clinically meaningful health
status data in Medicare managed care
for use in quality improvement
activities, plan accountability, public
reporting, and improving health. All
managed care plans with Medicare
Advantage (MA) contracts must
participate. CMS, in collaboration with
the National Committee for Quality
Assurance (NCQA), launched the
Medicare HOS as part of the
Effectiveness of Care component of the
former Health Plan Employer Data and
Information Set, now known as the
Healthcare Effectiveness Data and
Information Set (HEDIS®).
The HOS measure was developed
under the guidance of a technical expert
panel comprised of individuals with
specific expertise in the health care
industry and outcomes measurement.
The measure includes the most recent
advances in summarizing physical and
mental health outcomes results and
appropriate risk adjustment techniques.
In addition to health outcomes
measures, the HOS is used to collect the
Management of Urinary Incontinence in
E:\FR\FM\10AUN1.SGM
10AUN1
Agencies
[Federal Register Volume 77, Number 155 (Friday, August 10, 2012)]
[Notices]
[Pages 47848-47850]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2012-19675]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
[60-Day-12-0573]
Proposed Data Collections Submitted for Public Comment and
Recommendations
In compliance with the requirement of Section 3506(c)(2)(A) of the
Paperwork Reduction Act of 1995 for opportunity for public comment on
proposed data collection projects, the Centers for Disease Control and
Prevention (CDC) will publish periodic summaries of proposed projects.
To request more information on the proposed projects or to obtain a
copy of the data collection plans and instruments, call 404-639-7570
and send comments to Kimberly S. Lane, 1600 Clifton Road, MS-D74,
Atlanta, GA 30333 or send an email to omb@cdc.gov.
Comments are invited on: (a) Whether the proposed collection of
information is necessary for the proper performance of the functions of
the agency, including whether the information shall have practical
utility; (b) the accuracy of the agency's estimate of the burden of the
proposed collection of information; (c) ways to enhance the quality,
utility, and clarity of the information to be collected; and (d) ways
to minimize the burden of the collection of information on respondents,
including through the use of automated collection techniques or other
forms of information technology. Written comments should be received
within 60 days of this notice.
Proposed Project
National HIV Surveillance System (NHSS) (OMB No. 0920-0573,
Expiration 01/31/2013)-Revision- National Center for HIV/AIDS, Viral
Hepatitis, STD, and TB Prevention (NCHHSTP), Centers for Disease
Control and Prevention (CDC).
Background and Brief Description
CDC is authorized under Sections 304 and 306 of the Public Health
Service Act (42 U.S.C. 242b and 242k) to collect information on cases
of human immunodeficiency virus (HIV) and indicators of HIV disease and
HIV disease progression including AIDS. These national HIV surveillance
data collected by CDC are the primary source of information used to
monitor the extent and characteristics of the HIV burden in the U.S.
[[Page 47849]]
The purpose of HIV surveillance is to monitor trends in HIV and
describe the characteristics of infected persons (e.g., demographics,
modes of exposure to HIV, clinical and laboratory markers of HIV
disease, manifestations of severe HIV disease, and deaths among persons
with HIV). HIV surveillance data are widely used at all government
levels to assess the impact of HIV infection on morbidity and
mortality, to allocate medical care resources and services, and to
guide prevention and disease control activities.
As science, technology, and our understanding of HIV have evolved,
the NHSS has been updated periodically to meet the nation's needs for
information. CDC, in collaboration with health departments in the 50
states, the District of Columbia, and U.S. dependent areas, conduct
national surveillance for cases of HIV infection. National surveillance
includes tracking critical data across the spectrum of HIV disease from
HIV diagnosis, to AIDS, the end-stage disease caused by infection with
HIV, and death. In addition, this national system provides essential
data to estimate HIV incidence and monitor patterns in viral resistance
and HIV-1 subtypes, as well as provide information on perinatal
exposures in the U.S.
The CDC surveillance case definition has been modified periodically
to accurately monitor disease in adults, adolescents and children and
reflect use of new testing technologies and changes in HIV treatment.
Information is then updated in the case report forms and reporting
software as needed. In 2008, the surveillance case definitions for
adults and children for HIV and AIDS were revised. Since that time, the
enhanced HIV/AIDS reporting system (eHARS) was fully deployed (2010)
and forms have been updated to reflect those changes (2011). In 2012,
CDC convened an expert consultation to consider revisions of various
aspects of the case definition including criteria for reporting a
potential case, criteria for a reporting a confirmed case, and case
classification (disease staging system). Recommendations for revisions
in the case definition were adopted in a position statement by the
Council of State and Territorial Epidemiologists in June 2012 and the
final case definition revision is planned for 2012.
The revisions requested include modifications to currently
collected data elements and forms to align with anticipated changes in
the case definitions for HIV surveillance to be published in 2012 and
continuation of HIV surveillance activities funded under the new
funding opportunity announcement CDC-RFA-PS13-1302 National HIV
Surveillance System (NHSS). These include minor modifications of
testing categories to accommodate new testing algorithms and
modifications to staging criteria and non-substantial editorial changes
aimed at improving the format and usability of the forms such as
improved wording of terms and changes in the format of some response
options. In addition, the number of data elements from the former
enhanced perinatal surveillance (EPS) was reduced and the form modified
for continuation in 2013 as Perinatal HIV Exposure Reporting (PHER).
Surveillance data collection on variant and atypical strains (formerly
variant, atypical and resistant HIV surveillance (VARHS)) will be
continued as Molecular HIV Surveillance (MHS) with a reduced number of
data elements previously approved under VARHS.
CDC provides funding for 59 jurisdictions to conduct adult and
pediatric HIV case surveillance. Health department staffs compile
information from laboratories, physicians, hospitals, clinics and other
health care providers in order to complete the HIV and pediatric case
reports. CDC estimates that approximately 1,260 adult HIV case reports
and 6 pediatric case reports are processed by each health department
annually.
These data are recorded on standard case report forms, processed by
either paper or electronic format and entered into eHARS. Updates to
case reports are also entered into eHARS by health departments, as
additional information may be received from laboratories, vital
statistics offices, or additional providers. CDC estimates
approximately 1,469 updates to case reports will be processed by each
of the 59 health departments annually. Additionally, 5,876 updates of
laboratory test data will be processed, primarily through electronic
laboratory reporting, by each of the 59 health departments annually.
Health departments will de-identify compiled case report information
and forward to CDC on a monthly basis for inclusion in the national HIV
surveillance database. Evaluations are also conducted by health
departments on a subset of case reports (e.g. including re-abstraction/
validation activities and routine interstate de-duplication). CDC
estimates approximately 127 evaluations of case reports will be
processed by each of the jurisdictions annually.
Supplemental surveillance data are collected in a subset of areas
to provide additional information necessary to estimate HIV incidence,
to better describe the extent of HIV viral resistance and quantify HIV
subtypes among persons infected with HIV and to monitor and evaluate
perinatal HIV prevention efforts. Health departments funded for these
supplemental data collections obtain this information from
laboratories, health care providers, and medical records. CDC estimates
that 2,729 reports containing HIV Incidence Surveillance (HIS) data
elements will be processed on average by each of the 25 health
departments funded to collect incidence data annually. Additionally, an
estimated 718 reports containing additional data elements on HIV
nucleotide sequences from genotype test results will be processed on
average by each of the 53 health departments reporting MHS data
annually. An estimated 114 reports containing perinatal exposure data
elements will be processed on average, annually, by each of the 35
health departments reporting data collected as part of PHER.
There are no costs to respondents except their time.
Estimate of Annualized Burden Table
----------------------------------------------------------------------------------------------------------------
Number of Avg. burden Total annual
Type of respondent Form name Number of responses per per response burden (in
respondents respondent (in hours) hours)
----------------------------------------------------------------------------------------------------------------
Health Departments............ Adult HIV Case 59 1,260 20/60 24,780
Report.
Health Departments............ Pediatric HIV 59 6 20/60 118
Case Report.
Health Departments............ Case Report 59 127 20/60 2,498
Evaluations.
Health Departments............ Case Report 59 1,469 2/60 2,889
Updates.
Health Departments............ Laboratory 59 5,876 1/60 5,778
Updates.
Health Departments............ HIV Incidence 25 2,729 10/60 11,371
Surveillance
(HIS).
Health Departments............ Molecular HIV 53 967 5/60 4,271
Surveillance
(MHS).
[[Page 47850]]
Health Departments............ Perinatal HIV 35 114 30/60 1,995
Exposure
Reporting
(PHER).
---------------------------------------------------------------
Total..................... ................ .............. .............. .............. 53,700
----------------------------------------------------------------------------------------------------------------
Kimberly Lane,
Deputy Director, Office of Scientific Integrity, Centers for Disease
Control and Prevention.
[FR Doc. 2012-19675 Filed 8-9-12; 8:45 am]
BILLING CODE 4163-18-P